KI

Karunanithi Indhumathi

Active Director Director DIN 11056763
DIN 11056763 First appointment Apr 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Karunanithi Indhumathi

Data last updated:

Karunanithi Indhumathi is a Director at Wisher And Kinder Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11056763
Primary Designation Director
Industry Pharma
First Appointment 16 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Apr 20252025Active

Board colleagues of Karunanithi Indhumathi

Directorship timeline

Open interactive timeline →
Wisher And Kinder Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Karunanithi Indhumathi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Karunanithi Indhumathi

Karunanithi Indhumathi currently holds 1 directorship: Wisher And Kinder Pharmaceuticals Private Limited (Director, since 16 Apr 2025).

Karunanithi Indhumathi was first appointed on 16 Apr 2025 as Director at Wisher And Kinder Pharmaceuticals Private Limited.

The current boards of Karunanithi Indhumathi's companies include Natesan Deepa (Wisher And Kinder Pharmaceuticals Private Limited), Tiruchy Raju Manoharan (Wisher And Kinder Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available